IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $805,000 | +32.8% | 9,474 | -44.6% | 0.00% | 0.0% |
| Q2 2020 | $606,000 | +224.1% | 17,106 | +23.1% | 0.00% | +200.0% |
| Q1 2020 | $187,000 | -53.1% | 13,900 | -26.5% | 0.00% | -50.0% |
| Q4 2019 | $399,000 | -1.2% | 18,900 | -38.2% | 0.00% | +100.0% |
| Q3 2019 | $404,000 | -59.2% | 30,600 | -57.2% | 0.00% | -75.0% |
| Q2 2019 | $991,000 | -29.7% | 71,451 | -2.6% | 0.00% | -33.3% |
| Q1 2019 | $1,409,000 | +28.9% | 73,351 | -4.3% | 0.01% | 0.0% |
| Q4 2018 | $1,093,000 | -29.5% | 76,651 | +3.0% | 0.01% | -14.3% |
| Q3 2018 | $1,550,000 | +1.5% | 74,451 | +15.3% | 0.01% | 0.0% |
| Q2 2018 | $1,527,000 | +1227.8% | 64,551 | +136.5% | 0.01% | +600.0% |
| Q1 2014 | $115,000 | -8.7% | 27,300 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $126,000 | -33.3% | 27,300 | -10.5% | 0.00% | 0.0% |
| Q3 2013 | $189,000 | – | 30,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 4,750,000 | $112,433,000 | 20.02% |
| Avoro Capital Advisors LLC | 17,714,461 | $419,301,000 | 16.14% |
| Foresite Capital Management III, LLC | 2,541,729 | $60,163,000 | 12.96% |
| Foresite Capital Management IV, LLC | 1,231,543 | $29,151,000 | 9.94% |
| Ghost Tree Capital, LLC | 1,250,000 | $29,588,000 | 8.71% |
| NEXTHERA CAPITAL LP | 1,329,104 | $31,460,000 | 4.87% |
| RA Capital Management | 3,119,778 | $73,845,000 | 4.79% |
| DLD Asset Management, LP | 2,682,100 | $63,458,000 | 4.78% |
| Palo Alto Investors LP | 4,803,364 | $113,696,000 | 4.54% |
| DLD Asset Management, LP | 2,411,600 | $57,058,000 | 4.30% |